Business Process Outsourcing

The Research Foundation of the City University of New York (RF-CUNY) serves the nation’s largest urban public university, and manages grant awards exceeding $410 million in areas ranging from research in the natural and social sciences, training, job placement, curriculum planning, assessment, program evaluation, media production, and software development. The foundation has roughly 12,000 employees who serve in a variety of functions throughout CUNY’s 24 colleges, professional schools and off campus sights. The RF’s main function is to offer flexibility and respond quickly to the changing conditions and requirements of its many sponsors.

In the pharmaceutical and biopharmaceutical industry several factors have converged to change the landscape in regard to facilities.

Experts share some key considerations to help biopharmaceutical companies successfully advance a molecule from the laboratory to the clinic as quickly as possible  without sacrificing product quality, process efficiency, or patient safety.

One way to lower the suspension viscosity of a drug is through the use of highly-concentrated crystalline suspensions, or protein crystals.

Purpose-built SSU solutions track clinical trial operations using much needed standardized performance metrics.

While the wider use of opioids has led to many benefits for patients in pain, it also has led to higher incidences of misuse, abuse, and development of opioid addiction. 

Unlikely or unforeseen competitors continue to disrupt industries at an exponential pace. The innovation disruptors bring requires a key strategy: put the customer at the center of your business and deliver great experiences to them. Understand how consistent, timely, relevant and personalized experiences are enabled by having the right technology foundation in place.

Affordable housing developer Dominium is in the process of doubling in size, with plans for 40,000 units by 2025. Yet a manual, time-intensive work order-management and apartment inspection process hampered field staff. The company set out to ratchet up operational efficiency and worker productivity in a bid to deliver enhanced service to its residents at a faster clip.

As Pfizer began its pursuit of delivering two biosimilar monoclonal antibodies (mAbs) in China, it sought a partner that could mitigate the risks of expanding into this region while also significantly reducing the development timeline. By leveraging the expertise of an experienced partner and the benefits of single-use technology (SUT), Pfizer was able to quickly establish a global footprint while also gaining a competitive advantage in an emerging market.

The competition is fierce in the business process outsourcing (BPO) space. That’s why the benefits that DATAMARK is achieving for a major client with an ibml image and data capture solution are so impressive. The solution has helped DATAMARK reduce its labor requirements by more than 50 percent, accelerate delivery of information downstream, and decrease its overhead.

Gilead Sciences’ previous studies of Ranexa (ranolazine) relied on data from exercise treadmill parameters as the primary endpoint. But collecting data in this manner is costly, logistically challenging, and bears questionable clinical relevance — especially at the individual patient level. Learn how Gilead Sciences successfully utilized ERT handhelds to collect regulatory-compliant, patient-driven data in support of the primary efficacy endpoint in a Phase IV study of Ranexa.

Fisher Clinical Services was contacted in early 2013 by a virtual biotech that had a set of unique challenges. With just one compound in the pipeline, the company was in trouble because its previous vendor made drug supply errors that compromised patient safety in Phase II. Not only was the clinical team navigating the ethics investigation triggered by this violation of trust, the legal team was fending off lawsuits from investors.